Lv1
40 积分 2024-10-26 加入
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm
4天前
已完结
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
9天前
已完结
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia
11天前
已完结
If You Build It, Patients with Rare Cancers Will Come: A Successful Clinical Trial in Relapsed and Refractory JMML
13天前
已完结
If You Build It, Patients with Rare Cancers Will Come: A Successful Clinical Trial in Relapsed and Refractory JMML
13天前
已关闭
Characteristics of RAS pathway mutations in juvenile myelomonocytic leukaemia: a single‐institution study from Korea
13天前
已完结
Too many white cells—TAM, JMML, or something else?
13天前
已关闭
Juvenile myelomonocytic leukemia-A comprehensive review and recent advances in management
13天前
已完结
皖公网安备34019202002308
